|
Market Closed -
Nasdaq
06:00:00 23/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 2.010 USD | +4.15% |
|
-9.05% | +28.85% |
| 17/09 | Novartis halts ALS drug development after mid-stage trial failure | RE |
| 15/09 | Alector, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 07:00 AM |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ALEC | Delayed | |
CBOE
| ALEC | Real-time | |
Deutsche Boerse AG
| 0Z2 | Delayed | |
Börse Stuttgart
| 0Z2 | Delayed | |
Tradegate
| 0Z2 | Real-time | |
Boerse Muenchen
| 0Z2 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 2.72 | 2.72 | 3.04 |
| Spread/Res. | -26.10% | -26.10% | -33.88% |
| Spread/Supp. | +18.93% | +44.60% | +64.75% |
| Support | 1.69 | 1.39 | 1.22 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALEC Stock
- Charts Alector, Inc.
Select your edition
All financial news and data tailored to specific country editions

















